TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

MINOCIN

MINOCYCLINE HYDROCHLORIDE
Approved 1971-06-30
7
Indications
--
Phase 3 Trials
54
Years on Market

Details

Status
Discontinued
First Approved
1971-06-30
Routes
ORAL, INJECTION
Dosage Forms
CAPSULE, INJECTABLE, SUSPENSION

MINOCIN Approval History

Loading approval history...

What MINOCIN Treats

7 FDA approvals

Originally approved for its first indication in 1971 . Covers 7 distinct patient populations.

  • Other (7)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MINOCIN FDA Label Details

Pro

MINOCIN Patents & Exclusivity

Latest Patent: Oct 2032

Patents (4 active)

US11944634 Expires Oct 16, 2032
US9084802 Expires May 12, 2031
US9278105 Expires May 12, 2031
US12161656 Expires May 12, 2031
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.